Elan (ELN) Higher On Reports of Novartis Talks
More News related to ELN
- Elan Corporation Plc Announces Expiration of Tender Offer for 73/4% Senior Fixed Rate Notes Due 2011
- UBS Downgrades Elan (ELN) to Neutral
- Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease
- Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com
- Unusual 11 Mid-Day Movers 10/23: AMZN, SCSS, ALGN, EPAY Higher; ELN, SNV, CBRX, STSA Lower
More News related to NVS
- Trading Outlook for Novavax Inc. Issued by InvestorSoup.com
- Crucell NV (CRXL) Up On Renewed Takeover Chatter
- Hapoalim Securities Initiates Coverage on Nektar Therapeutics (NKTR) with a Buy; Ongoing Programs to Help Drive Share Price
- Novartis Champions Renewable Energy With New Vacaville Solar Array
- Trading Radar for 10/22: AT&T (T), McDonalds (MCD), Amazon.com (AMZN), 3M (MMM), Dow Chemical (DOW), UPS (UPS) Report
Shares of Elan (NYSE: ELN) are higher in overseas trading following reports in the Sunday Times, Novartis (NYSE: NVS) is in talks to buy part of the Dublin, Ireland-based drugmaker.
Spokespersons from both companies declined to comment on the speculation.
The Sunday Times cited a "well-placed source" which said a decision is "some way off."
Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
Mergers and AcquisitionsMomentum Movers
Rumors
Stocks Mentioned
+0.38Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
